Madeleine Kennedy

Madeleine Kennedy

Director/Board Member at NUFORMIX PLC

Net worth: 45 867 $ as of 31/07/2026

61 year
Health Technology
Communications
Commercial Services

Profile

Ms. Madeleine E.
Kennedy is a Chief Financial Officer at Arquer Diagnostics Ltd., a Chief Financial Officer at Genesis Technical Systems (UK) Ltd. and a Chief Financial Officer at Tetris Pharma Ltd. She is on the Board of Directors at Nuformix Plc and Nuformix Technologies Ltd. Ms. Kennedy was previously employed as a Chief Financial Officer & Director by MyHealthChecked Plc, a Chief Financial Officer by Lab 21 Ltd., a Chief Financial Officer by Akamis Bio Ltd., a Finance Director by Alliance Pharma Ltd., a Chief Financial Officer by Ieso Digital Health Ltd., a Principal by McCann Erickson (Germany), a Principal by Nokia UK Ltd., and a Principal by Serco, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/11/2025 23,521,428 ( 0.9% ) 45 867 $ 31/07/2026

Madeleine Kennedy active positions

CompaniesPositionStart
NUFORMIX PLC Director/Board Member 02/12/2020
Director of Finance/CFO -
Director of Finance/CFO -
Director of Finance/CFO -
Director/Board Member -

Former positions of Madeleine Kennedy

CompaniesPositionEnd
FORTIS FRONTIER PLC Director of Finance/CFO 04/06/2021
Director of Finance/CFO 01/11/2010
Director of Finance/CFO -
Director of Finance/CFO -
░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ -
See the detail of Madeleine Kennedy's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Communications

Commercial Services

Health Services

Industrial Services

Health Services

Health Technology

Commercial Services

Health Technology

Communications

Health Technology

Health Technology

Distribution Services

  1. Stock Market
  2. Insiders
  3. Madeleine Kennedy
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!